Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Allon Therapeutics Inc NPCUF

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and... see more

GREY:NPCUF - Post Discussion

Allon Therapeutics Inc > NAPEC: AWAITING A TAKEOVER OFFER
View:
Post by modulex on Oct 19, 2017 6:17pm

NAPEC: AWAITING A TAKEOVER OFFER

napec's book-value is $1.15/share. the stock has experienced above trading volumes for now a month, even slightly more, on no news, so far. it is moving up and down, within a range of $0.10. this trend signals that something is pending about the company. DONT THINK A MINUTE THAT THE STOCK WILL GO DOWN AGAIN TO $1.00, IT WONT HAPPENED. after many years as a public company, having been unable to create the level of shareholders value, with a stock that has never performed at more than approximately $1.50/share at least in the past five years, if i am not mistaken, management most likely know that a stronger company can make thrive its assets rather than remaining a stand-alone company. q3 results are to be released around november 10, so time is approaching for something to unfold.
Comment by Vimon66 on Oct 21, 2017 6:40am
"DONT THINK A MINUTE THAT THE STOCK WILL GO DOWN AGAIN TO $1.00, IT WONT HAPPENED". Glad tout hear this.... but can't help being a little surprised before such certainty and at the same time curious of a reasonable per share takeover offer you would estimate possible. Thx!
Comment by CBalardo on Oct 22, 2017 1:12am
Well this is a great stock at the wrong time! The predict the stock market is about to go though some wobbly times in the next while. I bought this stock at .74 cents 1.05 and again at 1.12 but had to pull back my positions on this stock and two others. This will be the first stock I jump into once the markets especially the Dow jones settle out where they should be. I think this stock will shine ...more  
Comment by retiredcf on Oct 22, 2017 4:46pm
While it's always good to take profits your timing may be a bit off. After treading water from April to August, we finally got going in Sep and this is continuing in Oct. Remember that Sep is traditionally the worst month of the year for markets and we are soon to be heading into the strongest 3 month period. And while he's extremely unreliable, if Trump's tax plan comes to pass, the ...more  
Comment by Vimon66 on Oct 27, 2017 5:15am
Are there any trustworthy rumors flying around business circles on a potential takeover? Because it seems to me that apart from what bas been written on this blog, there is absolutly nothing. Moreover, what'up with NPC's investors relation...it seems like they don't care a bit to keep us informed.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities